- Home
- QSI vs EVMN Comparison
QSI vs EVMN Comparison
Compare QSI & EVMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | QSI | EVMN |
|---|---|---|
| Founded | 2013 | 2020 |
| Country | United States | United States |
| Employees | N/A | 48 |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 165.6M | 185.1M |
| IPO Year | 2020 | 2025 |
Fundamental Metrics
Financial Performance| Metric | QSI | EVMN |
|---|---|---|
| Price | $1.38 | $5.11 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 12 |
| Target Price | $2.30 | ★ $22.33 |
| AVG Volume (30 Days) | ★ 9.3M | 780.3K |
| Earning Date | 11-05-2026 | 11-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 28.17 | ★ 75.23 |
| EPS | ★ N/A | N/A |
| Revenue | $2,436,000.00 | ★ $13,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $406.32 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 85.71 |
| 52 Week Low | $0.69 | $5.09 |
| 52 Week High | $2.42 | $33.20 |
Technical Indicators
Market Signals| Indicator | QSI | EVMN |
|---|---|---|
| Relative Strength Index (RSI) | 60.23 | 20.59 |
| Support Level | $0.81 | N/A |
| Resistance Level | $1.66 | $13.35 |
| Average True Range (ATR) | 0.17 | 0.36 |
| MACD | -0.02 | 0.08 |
| Stochastic Oscillator | 59.23 | 10.69 |
Price Performance
Historical ComparisonAbout QSI Quantum-Si Incorporated
Quantum-Si Inc is a life sciences company focused on proteomics research and analytical technologies. It develops single-molecule detection platforms designed to enable next-generation protein sequencing (NGPS) and large-scale protein analysis. Its technology supports massively parallel sequencing of proteins and can also be applied to the study of nucleic acids, providing tools for researchers and clinical applications in molecular analysis. The company's revenue is derived from sales of products and services.
About EVMN Evommune Inc.
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.